Dafna Capital Management LLC Incyte Corp Transaction History

Dafna Capital Management LLC

  • $389 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 15, 2019
SELL
$63.56 - $88.17 $1.37 Million - $1.9 Million
-21,500 Closed
0 $0
Q2 2018

Aug 13, 2018
BUY
$60.85 - $83.98 $395,525 - $545,870
6,500 Added 43.33%
21,500 $1.44 Million
Q1 2018

May 15, 2018
BUY
$83.06 - $100.98 $1.25 Million - $1.51 Million
15,000 New
15,000 $1.25 Million

Others Institutions Holding INCY

# of Institutions
657
Shares Held
186M
Call Options Held
714K
Put Options Held
557K
View Full List

About INCYTE CORP

INCY Quotes by TradingView
  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $16.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Dafna Capital Management LLC Portfolio

Follow Dafna Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dafna Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dafna Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email